Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
J Biol Regul Homeost Agents ; 34(3): 977-986, 2020.
Article de Anglais | MEDLINE | ID: mdl-32664712

RÉSUMÉ

Chlamydia trachomatis, the leading cause of bacterial sexually transmitted diseases worldwide, can disseminate and localize to the upper genital tract impairing reproductive function. Specifically, ascending C. trachomatis genital infection has been demonstrated to cause epididymitis or epididymo-orchitis, well-known risk factors for male infertility. C. trachomatis possesses the ability to infect primary human Sertoli cells, key elements for the spermatogenetic process and the immune protection of germ cells. Therefore, herein, we investigated the innate immune response in Sertoli cells following C. trachomatis infection, as well as its indirect effects on human spermatozoa. Specifically, we evaluated C. trachomatis mediated induction of Toll-like Receptors (TLR) 2, 3 and 4 as well as of downstream intracellular signaling molecules (NFκB and IRF3) and the levels of the related inflammatory mediators (IL-1α, IL-6, IFN-α, IFN-ß and IFN-γ), in an in vitro infection model of primary human Sertoli cells. The main result of our study shows that C. trachomatis induced TLR3-mediated recognition in human Sertoli cells, accompanied by the down-modulation of NFκB and IRF3-dependent signaling pathways followed by no production of pro-inflammatory cytokines. In conclusion, our findings suggest that C. trachomatis can disrupt the innate immune response in Sertoli cells and evade intracellular killing, potentially giving rise to a long-term infection that may exert negative effects on the male reproductive system.


Sujet(s)
Chlamydia trachomatis , Facteur-3 de régulation d'interféron/métabolisme , Facteur de transcription NF-kappa B/métabolisme , Cellules de Sertoli/microbiologie , Transduction du signal , Récepteur de type Toll-3/métabolisme , Cellules cultivées , Infections à Chlamydia , Humains , Interférons/métabolisme , Interleukines/métabolisme , Mâle , Cellules de Sertoli/métabolisme
2.
J Endocrinol Invest ; 42(7): 833-842, 2019 Jul.
Article de Anglais | MEDLINE | ID: mdl-30499012

RÉSUMÉ

PURPOSE: The aim of this study was to study the incidence of Y chromosome microdeletions in a Caucasian population of Klinefelter syndrome (KS) patients and to investigate the possible association between Y chromosome microdeletions and KS. MATERIALS AND METHODS: We conducted a retrospective study on 118 KS patients, 429 patients with non-obstructive azoospermia (NOA), and 155 normozoospermic men. Eight of the 118 KS patients had undergone testicular sperm extraction (TESE). All patients underwent semen examination and Y chromosome microdeletions evaluated by PCR, using specific sequence tagged site (STS) primer sets, which spanned the azoospermia factor AZFa, AZFb, and AZFc regions of the Y chromosome. RESULTS: Semen analysis of the KS group revealed: 1 patient with oligozoospermia, 1 with severe oligoasthenoteratozoospermia, 2 with cryptozoospermia, and 114 with azoospermia. Eight of the 114 azoospermic KS patients underwent TESE, and spermatozoa were recovered from three of these, all of whom had non-mosaic karyotype 47, XXY. 10.7% of the NOA patients presented AZF microdeletions. In 429 cases with NOA, 8 cases had AZFa + b + c deletion, 6 cases had AZF b + c deletion, 4 cases had AZFa microdeletion, 8 cases had AZFb microdeletion, and 20 cases had AZFc microdeletion. Just one KS patient (0.8%) presented microdeletion in the AZFc region. CONCLUSION: The percentage of microdeletions in KS patients was lower than in NOA patients, suggesting that AZF microdeletions and KS do not have a causal relationship and that Y chromosome microdeletions are not a genetic factor linked to KS.


Sujet(s)
Marqueurs biologiques/analyse , Délétion de segment de chromosome , Chromosomes Y humains/génétique , Syndrome de Klinefelter/épidémiologie , Syndrome de Klinefelter/génétique , Adulte , Études cas-témoins , Femelle , Études de suivi , Humains , Incidence , Italie/épidémiologie , Syndrome de Klinefelter/anatomopathologie , Mâle , Pronostic , Études rétrospectives
3.
J Endocrinol Invest ; 41(7): 781-787, 2018 Jul.
Article de Anglais | MEDLINE | ID: mdl-29247344

RÉSUMÉ

BACKGROUND: Sperm motility is an essential aspect of human fertility. Sperm contain an abundance of transcripts, thought to be remnants of mRNA, which comprise a genetic fingerprint and can be considered a historic record of gene expression during spermatogenesis. The aberrant expression of numerous genes has been found to contribute to impaired sperm motility; these include ROPN1 (rhophilin associated tail protein 1), which encodes a component of the fibrous sheath of the mammalian sperm flagella, and CABYR (calcium-binding tyrosine-(Y)-phosphorylation-regulated protein), which plays an important role in calcium activation and modulation. The aim of this study was to investigate ROPN1 and CABYR gene co-expression in asthenozoospermic semen samples in comparison with normozoospermic samples. METHODS: We studied 120 semen samples (60 normozoospermic and 60 asthenozoospermic) from Caucasian patients attending our centre for an andrological check-up. Total RNA was extracted from purified spermatozoa with RNeasy mini kit. ROPN1 and CABYR mRNA expression was analysed using RT-qPCR. Continuous variables were described as means ± standard deviations. RESULTS: ROPN1 and CABYR mRNA were simultaneously downregulated in asthenozoospermic in comparison with normozoospermic samples. There was also a positive correlation between total progressive motility and ROPN1 and CABYR gene expression and between total motile sperm number and ROPN1 and CABYR gene expression. CONCLUSIONS: The results demonstrated downregulation of both ROPN1 and CABYR in asthenozoospermic samples and importantly, a positive correlation between the expression of the two genes, suggesting that ROPN1 and CABYR co-expression is a prerequisite for normal flagellar function and sperm motility.


Sujet(s)
Asthénozoospermie/génétique , Protéines de liaison au calcium/génétique , Protéines membranaires/génétique , Phosphoprotéines/génétique , ARN/analyse , Spermatozoïdes/métabolisme , Protéines G rho/génétique , Adolescent , Adulte , Asthénozoospermie/anatomopathologie , Protéines de liaison au calcium/analyse , Humains , Mâle , Protéines membranaires/analyse , Adulte d'âge moyen , Phosphoprotéines/analyse , ARN/métabolisme , Analyse du sperme , Analyse de séquence d'ARN , Mobilité des spermatozoïdes/génétique , Flagelle du spermatozoïde/physiologie , Spermatozoïdes/composition chimique , Spermatozoïdes/anatomopathologie , Jeune adulte , Protéines G rho/analyse
4.
Minerva Chir ; 68(1): 1-9, 2013 Feb.
Article de Anglais | MEDLINE | ID: mdl-23584262

RÉSUMÉ

Transanal endoscopic microsurgery (TEM) is a minimally invasive technique that was introduced by Buess in the early 1980s. The TEM procedure employs a dedicated rectoscope with a 3D binocular optic and a set of endoscopic surgical instruments. Since the beginning its advantages have been evident: magnification of the operative field, better access to proximal lesions with lower margin positivity and fragmentation over traditional transanal excision techniques. A non-systematic literature search was performed in the PubMed database to identify all original articles on rectal cancer treated by TEM. Only series including at least ten cases of adenocarcinoma with two years' mean minimum follow-up and published in English were selected. Nowadays more than two decades of scientific data support the use of TEM in the treatment of selected patients with non-advanced rectal cancer. This paper describes the indications and the surgical technique of TEM in the treatment of rectal cancer.


Sujet(s)
Adénocarcinome/chirurgie , Proctoscopie/méthodes , Tumeurs du rectum/chirurgie , Adénocarcinome/anatomopathologie , Médecine factuelle , Humains , Stadification tumorale , Proctoscopie/instrumentation , Tumeurs du rectum/anatomopathologie , Résultat thérapeutique
5.
Am J Clin Nutr ; 55(6 Suppl): 1208S-1214S, 1992 06.
Article de Anglais | MEDLINE | ID: mdl-1590258

RÉSUMÉ

Cells continuously exposed to genotoxic agents, such as oxygen free radicals (OFRs), deeply involved in the aging process use a variety of cellular defense mechanisms. These defense mechanisms include DNA repair enzymes, antioxidants, poly(ADP-ribosyl)polymerase (pADPRP), and stress proteins and they constitute an integrated network. An age-related failure of the efficiency of this network can affect cell proliferation and cell death, two phenomena tightly linked and regulated. Recent data from our laboratory on the role of DNA damage and pADPRP activation and on the type of cell death induced by OFRs in human lymphocytes are reviewed. In vitro and in vivo data on possible strategies to reduce oxidative stress in lymphocytes from normal and Down syndrome subjects, by using natural compounds and trace elements, are presented. They indicate that nicotinamide and L-carnitine protect human cells from OFR-induced damage and suggest that they are possible candidates as antiaging substances.


Sujet(s)
Vieillissement/physiologie , Mort cellulaire/physiologie , Altération de l'ADN/physiologie , Radicaux libres , Humains , Oxydoréduction , Oxygène/métabolisme , Poly(ADP-ribose) polymerases/physiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...